Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3FDN

Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity

Summary for 3FDN
Entry DOI10.2210/pdb3fdn/pdb
DescriptorSerine/threonine-protein kinase 6, N-[3-(acetylamino)phenyl]-5-{(2E)-2-[(4-methoxyphenyl)methylidene]hydrazino}-3-methyl-1H-pyrazole-4-carboxamide (3 entities in total)
Functional Keywordsaurora kinase inhibitors, virtual screening, x-ray co-crystal analysis, structure-based drug design (sbdd), h-bonding., atp-binding, cell cycle, kinase, nucleotide-binding, phosphoprotein, polymorphism, serine/threonine-protein kinase, transferase
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm, cytoskeleton, centrosome: O14965
Total number of polymer chains1
Total formula weight32765.56
Authors
Leou, J.S.,Wu, J.S.,Coumar, M.S.,Shukla, P.,Hsieh, H.P.,Wu, S.Y. (deposition date: 2008-11-26, release date: 2009-09-15, Last modification date: 2023-11-01)
Primary citationCoumar, M.S.,Leou, J.S.,Shukla, P.,Wu, J.S.,Dixit, A.K.,Lin, W.H.,Chang, C.Y.,Lien, T.W.,Tan, U.K.,Chen, C.H.,Hsu, J.T.A.,Chao, Y.S.,Wu, S.Y.,Hsieh, H.P.
Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity
J.Med.Chem., 52:1050-1062, 2009
Cited by
PubMed Abstract: Aurora kinases have emerged as attractive targets for the design of anticancer drugs. Through structure-based virtual screening, novel pyrazole hit 8a was identified as Aurora kinase A inhibitor (IC(50) = 15.1 microM). X-ray cocrystal structure of 8a in complex with Aurora A protein revealed the C-4 position ethyl carboxylate side chain as a possible modification site for improving the potency. On the basis of this insight, bioisosteric replacement of the ester with amide linkage and changing the ethyl substituent to hydrophobic 3-acetamidophenyl ring led to the identification of 12w with a approximately 450-fold improved Aurora kinase A inhibition potency (IC(50) = 33 nM), compared to 8a. Compound 12w showed selective inhibition of Aurora A kinase over Aurora B/C, which might be due to the presence of a unique H-bond interaction between the 3-acetamido group and the Aurora A nonconserved Thr217 residue, which in Aurora B/C is Glu and found to sterically clash with the 3-acetamido group in modeling studies.
PubMed: 19140666
DOI: 10.1021/jm801270e
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon